Response Oncology, Inc. (ROIX)

0.0000 0.0000 (0.00%) At close: 09:30AM EDT

Response Oncology, Inc.

1805 Moriah Woods Boulevard
Memphis, TN 38117
United States
901-761-7000

Sector(s): 
Industry: 
Full-time employees: 10

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Charles E. Sweet	Chairman of the Board, Chief Executive Officer and President	N/A	N/A	1957

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.

Corporate governance

Response Oncology, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.